V1 sact_regimen
730,471 rows · 12 columns
| MERGED_REGIMEN_ID | MERGED_TUMOUR_ID | HEIGHT_AT_START_OF_REGIMEN | WEIGHT_AT_START_OF_REGIMEN | INTENT_OF_TREATMENT | DATE_DECISION_TO_TREAT | START_DATE_OF_REGIMEN | MAPPED_REGIMEN | CLINICAL_TRIAL | CHEMO_RADIATION | MERGED_PATIENT_ID | BENCHMARK_GROUP |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 310007585 | 310004750 | 1.79 | 68 | Curative (C) | 2014-09-06 | 2014-09-28 | Cisplatin 100 + RT(H&N) 1 day | N | null | 310018762 | CISPLATIN + RT |
| 310007586 | 310004751 | 1.73 | 74.6 | Disease modification (D) | 2016-10-10 | 2016-10-11 | Etoposide oral | N | N | 310018766 | ETOPOSIDE |
| 310007587 | 310008034 | 1.8 | 0 | Palliative (P) | 2016-10-06 | 2017-01-27 | Docetaxel+Gemcitabine (no prior RT) | 02 | null | 310018767 | DOCETAXEL + GEMCITABINE |
| 310007588 | 310008034 | 1.6 | 79.3 | null | 2014-11-17 | 2014-11-17 | Ipilimumab | 02 | N | 310018767 | IPILIMUMAB |
| 310007589 | 310004752 | null | 59.3 | Palliative (P) | 2016-07-05 | 2016-07-08 | CHOP R - 21 days | N | null | 310018774 | CHOP R |
| 310007590 | 310004754 | null | 73.1 | Curative (C) | 2017-12-31 | 2018-01-13 | GDP | 2 | N | 310018775 | GDP |
| 310007591 | 310004755 | 1.75 | 67.7 | Palliative (P) | 2015-04-19 | 2015-04-28 | CYCLOPHOSPHAMIDE | N | N | 310018778 | CYCLOPHOSPHAMIDE |
| 310007592 | 310004758 | 1.65 | 64.4 | Curative (C) | 2015-09-16 | 2015-09-17 | Methotrexate Intrathecal (any age) | null | null | 310018779 | METHOTREXATE INTRATHECAL |
| 310007593 | 310004759 | 1.56 | null | Disease modification (D) | 2016-05-17 | 2016-06-10 | Cyclophosphamide oral | 02 | N | 310018784 | CYCLOPHOSPHAMIDE |
| 310007594 | 310004759 | 1.52 | null | Palliative (P) | 2016-04-15 | 2016-04-26 | GDP | 02 | N | 310018784 | GDP |
| 310007595 | 310004759 | 1.64 | null | null | null | 2018-02-21 | Docetaxel | N | N | 310018784 | DOCETAXEL |
| 310007596 | 310004760 | null | null | Palliative (P) | 2015-06-03 | 2015-06-10 | Docetaxel 75mg/m2 (21 day) | 02 | N | 310018788 | DOCETAXEL |
| 310007597 | 310004761 | null | 55.2 | Curative (C) | 2015-01-15 | 2015-03-08 | ETOPOSIDE | 02 | N | 310018804 | ETOPOSIDE |
| 310007598 | 310004761 | 1.7 | null | Adjuvant (A) | 2013-05-30 | 2013-06-04 | Cisplatin + Radiotherapy | N | N | 310018804 | CISPLATIN + RT |
| 310007599 | 310004761 | 1.78 | 71.8 | Curative (C) | 2015-06-16 | 2015-06-20 | Bexarotene | N | N | 310018804 | ESHAP |
| 310007600 | 310008041 | 1.71 | 96.4 | Curative (C) | 2016-09-20 | 2016-09-24 | Methotrexate intrathecal | N | N | 310018813 | METHOTREXATE INTRATHECAL |
| 310007601 | 310004764 | 1.69 | 91.7 | Palliative (P) | 2016-02-25 | 2017-03-31 | CYCLOPHOSPHAMIDE + MESNA | N | N | 310018814 | CYCLOPHOSPHAMIDE |
| 310007602 | 310004765 | 1.85 | 104.4 | Palliative (P) | 2016-09-12 | 2016-10-03 | CYCLOPHOSPHAMIDE | N | N | 310018818 | CYCLOPHOSPHAMIDE |
| 310007603 | 310004765 | 1.8 | 72.1 | null | 2017-11-05 | 2017-11-14 | ESHAP | N | N | 310018818 | CARBOPLATIN + ETOPOSIDE |
| 310007604 | 310011262 | 1.66 | 52.3 | Palliative (P) | 2017-06-17 | 2017-06-18 | ETOPOSIDE | N | N | 310018831 | ETOPOSIDE |
| 310007605 | 310011548 | 1.62 | null | null | 2018-05-18 | 2018-11-20 | BEVACIZUMAB + CARBO + PACLITAXEL | N | N | 310018848 | BEVACIZUMAB + CARBO + PACLITAXEL |
| 310007606 | 310008043 | 1.74 | 93.5 | Palliative (P) | 2019-07-04 | 2019-07-18 | Ipilimumab | null | null | 310018851 | IPILIMUMAB |
| 310007607 | 310004767 | 1.65 | 74 | Neo-adjuvant (N) | 2015-04-21 | 2015-07-07 | Carboplatin + Etoposide iv&po | 02 | N | 310018851 | ESHAP |
| 310007608 | 310004770 | 1.72 | 71 | Curative (C) | null | 2016-06-26 | CHOP R - 21 days | null | null | 310018858 | CHOP R |
| 310007609 | 310004773 | null | 74 | Disease modification (D) | 2014-05-24 | 2014-05-24 | Methotrexate intrathecal | null | null | 310018859 | METHOTREXATE INTRATHECAL |
| 310007610 | 310004774 | 1.62 | 67 | Palliative (P) | 2018-04-02 | 2018-04-09 | Bevacizumab + CARBOPLATIN + PACLITAXEL | N | N | 310018859 | BEVACIZUMAB + CARBOPLATIN + PACLITAXEL |
| 310007611 | 310004777 | null | 98.6 | Palliative (P) | 2016-04-28 | 2016-04-28 | CARBOPLATIN + ETOPOSIDE | Y | N | 310018884 | BEVACIZUMAB + CARBOPLATIN + PACLITAXEL |
| 310007612 | 310004779 | null | null | Curative (C) | 2017-09-16 | 2017-10-14 | GDP | 2 | N | 310018888 | GDP |
| 310007613 | 310009789 | 1.7 | 83 | Curative (C) | 2017-06-30 | 2017-06-30 | Bevacizumab + CARBOPLATIN + PACLITAXEL | N | N | 310018895 | UKALL2011 |
| 310007614 | 310004784 | 1.72 | 89 | Curative (C) | 2015-03-04 | 2015-08-23 | Cyclophosphamide High Dose | N | N | 310018896 | CYCLOPHOSPHAMIDE HIGH DOSE |
| 310007615 | 310008053 | 1.89 | 58.2 | Neo-adjuvant (N) | 2015-01-31 | 2015-02-02 | Carboplatin + Etoposide iv&po | N | N | 310018898 | ESHAP |
| 310007616 | 310004789 | 1.56 | 83 | Disease modification (D) | 2013-09-02 | 2013-09-02 | CISPLATIN + RT | 02 | N | 310018899 | CISPLATIN + RT |
| 310007617 | 310004790 | 1.71 | 100 | Palliative (P) | 2016-10-05 | 2016-10-19 | Bevacizumab + CARBOPLATIN + PACLITAXEL | N | N | 310018900 | BEVACIZUMAB + CARBOPLATIN + PACLITAXEL |
| 310007618 | 310008055 | 1.73 | 58 | Curative (C) | 2014-08-12 | 2014-08-27 | Cisplatin + Radiotherapy | 02 | N | 310018900 | CISPLATIN + RT |
| 310007619 | 310004792 | 1.69 | 108.9 | Palliative (P) | null | 2017-04-23 | Rituximab | null | null | 310018905 | RITUXIMAB |
| 310007620 | 310004792 | null | 96 | Curative (C) | null | 2014-06-29 | Cisplatin 100 + RT(H&N) 1 day | 2 | null | 310018905 | CISPLATIN + RT |
| 310007621 | 310004792 | 1.62 | 57.4 | Palliative (P) | 2014-09-18 | 2014-09-18 | BEVACIZUMAB + CARBO + PACLITAXEL | 02 | N | 310018905 | BEVACIZUMAB + CARBO + PACLITAXEL |
| 310007622 | 310004796 | 1.63 | 86.6 | Curative (C) | 2018-10-10 | 2018-10-21 | Cyclophosphamide oral | N | N | 310018921 | CYCLOPHOSPHAMIDE |
| 310007623 | 310004796 | null | 136.3 | null | 2016-03-22 | 2016-04-04 | Docetaxel + Gemcitabine (prior RT) | 2 | N | 310018921 | DOCETAXEL + GEMCITABINE |
| 310007624 | 310004797 | 0 | 68 | Palliative (P) | 2015-12-23 | 2015-12-23 | ESHAP | N | N | 310018929 | ESHAP |
| 310007625 | 310004798 | 1.51 | 69.3 | Curative (C) | 2015-07-17 | 2016-12-09 | Cisplatin | N | N | 310018941 | CISPLATIN |
| 310007626 | 310004798 | 1.73 | 91.7 | null | 2014-03-06 | 2014-03-06 | Methotrexate intrathecal | N | N | 310018941 | METHOTREXATE INTRATHECAL |
| 310007627 | 310004802 | 1.6 | 68.3 | null | null | 2018-01-10 | Methotrexate intrathecal | N | N | 310018945 | METHOTREXATE INTRATHECAL |
| 310007628 | 310004803 | 1.8 | 80.2 | Curative (C) | 2014-04-25 | 2014-08-02 | GDP | N | N | 310018945 | GDP |
| 310007631 | 310004807 | 1.62 | 57.6 | Palliative (P) | 2019-04-01 | 2019-07-30 | BEVACIZUMAB + CARBO + PACLITAXEL | N | N | 310018961 | BEVACIZUMAB + CARBO + PACLITAXEL |
| 310007632 | 310004808 | 1.7 | 51.95 | Palliative (P) | 2013-08-02 | 2013-08-10 | Bevacizumab+Carbo+Pacliaxel | N | N | 310018964 | BEVACIZUMAB + CARBO + PACLITAXEL |
| 310007633 | 310004808 | 1.66 | 49 | Curative (C) | 2015-04-10 | 2015-04-12 | GDP | 2 | N | 310018964 | GDP |
| 310007634 | 310004813 | 1.58 | 63.7 | Palliative (P) | 2018-07-23 | 2018-07-23 | Docetaxel 75mg/m2 (21 day) | 02 | N | 310018971 | DOCETAXEL |
| 310007635 | 310004814 | 1.63 | 63 | Curative (C) | 2016-01-16 | 2016-03-04 | ETOPOSIDE | 02 | Y | 310018975 | ETOPOSIDE |
| 310007636 | 310004814 | 0 | 99.7 | null | 2015-02-21 | 2015-07-25 | Ipilimumab | 02 | N | 310018975 | IPILIMUMAB |